1. Muller N, de la Roche, M* de la Roche M* Insights from the bottom-up development of LGR5-targeting immunotherapeutics. Immunotherapy Advances, 5(1), 2025. *Corresponding authors.
2. Chen H-C, Mueller N, Stott K, … de la Roche M* and de la Roche M* Novel immunotherapeutics against LGR5 to target multiple cancer types. EMBO Mol Med: 16:2223-2261. 2024. *Corresponding authors.
3. Rannikmae, H., Peel, S., Barry, S., Senda, T, de la Roche, M. Mutational inactivation of Apc in the intestinal epithelia compromises cellular organisation. J. Cell Sci. 2021.
4. Urbischek, M, Rannikmae, H, Foets, T, Ravn, K, Hyvonen, M, de la Roche, M. Organoid culture media containing growth factors of defined cellular activity. Scientific Reports. 2019.

All publications for Marc de la Roche